# Wells Fargo & Company: Form 10-Q for the period ended Sep 30, 2024

- Company: [Wells Fargo & Company](/companies/wfc.md) (CIK 72971)
- Form: 10-Q
- Filed: 2024-10-31
- Accepted by EDGAR: Oct 31, 2024, 20:32 ET
- Period: 2024-09-30
- Accession: 0000072971-24-000243
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/72971/000007297124000243/wfc-20240930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/72971/000007297124000243/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-07-01 to 2024-09-30 | $20.37bn | us-gaap:RevenuesNetOfInterestExpense |
| Revenue | 9 months, 2024-01-01 to 2024-09-30 | $61.92bn | us-gaap:RevenuesNetOfInterestExpense |
| Income tax | 3 months, 2024-07-01 to 2024-09-30 | $1.06bn | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2024-01-01 to 2024-09-30 | $3.28bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-07-01 to 2024-09-30 | $5.11bn | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2024-01-01 to 2024-09-30 | $14.64bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-07-01 to 2024-09-30 | $1.42 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2024-01-01 to 2024-09-30 | $3.94 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-07-01 to 2024-09-30 | $1.43 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2024-01-01 to 2024-09-30 | $3.99 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-07-01 to 2024-09-30 | 3,425,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2024-01-01 to 2024-09-30 | 3,503,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2024-01-01 to 2024-09-30 | −$5.87bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months, 2024-01-01 to 2024-09-30 | $3.81bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2024-01-01 to 2024-09-30 | $15.45bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | at 2024-09-30 | $1.92tn | us-gaap:Assets |
| Total liabilities | at 2024-09-30 | $1.74tn | us-gaap:Liabilities |
| Long-term debt | at 2024-09-30 | $182.01bn | us-gaap:LongTermDebt |
| Short-term borrowings | at 2024-09-30 | $111.89bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2024-09-30 | $183.26bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 790 characters.

The following table shows Company repurchases of its common stock for each calendar month in the quarter ended September 30, 2024.

| Calendar month | Total number of shares repurchased (1) | Weighted average price paid per share | Approximate dollar value of shares that may yet be repurchased under the authorization (in millions) |
| --- | ---: | ---: | ---: |
| July | 42 | $57.73 | $14,709 |
| August | 34,916,207 | 55.03 | 12,787 |
| September | 27,078,797 | 55.90 | 11,274 |
| Total | 61,995,046 |  |  |

(1) All shares were repurchased under an authorization covering up to $30 billion of common stock approved by the Board of Directors and publicly announced by the Company on July 25, 2023. Unless modified or revoked by the Board of Directors, this authorization does not expire.

## Risk factors

As filed, 179 characters.

Information in response to this item can be found under the “Financial Review – Risk Factors” section in this Report which information is incorporated by reference into this item.

Filed Oct 31, 2024.
Source: SEC EDGAR, the filing index for accession 0000072971-24-000243. Last ingested by Listed: Nov 10, 2026, 00:29 ET. No prices; not investment advice.